SNDX
Price
$9.85
Change
-$0.96 (-8.88%)
Updated
May 23 closing price
Capitalization
930.17M
79 days until earnings call
SRRK
Price
$30.00
Change
-$0.72 (-2.34%)
Updated
May 23 closing price
Capitalization
2.89B
74 days until earnings call
Interact to see
Advertisement

SNDX vs SRRK

Header iconSNDX vs SRRK Comparison
Open Charts SNDX vs SRRKBanner chart's image
Syndax Pharmaceuticals
Price$9.85
Change-$0.96 (-8.88%)
Volume$3.9M
Capitalization930.17M
Scholar Rock Holding
Price$30.00
Change-$0.72 (-2.34%)
Volume$825.2K
Capitalization2.89B
SNDX vs SRRK Comparison Chart
Loading...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNDX vs. SRRK commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNDX is a Hold and SRRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (SNDX: $10.81 vs. SRRK: $30.46)
Brand notoriety: SNDX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNDX: 124% vs. SRRK: 51%
Market capitalization -- SNDX: $930.17M vs. SRRK: $2.89B
SNDX [@Biotechnology] is valued at $930.17M. SRRK’s [@Biotechnology] market capitalization is $2.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNDX’s FA Score shows that 1 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • SNDX’s FA Score: 1 green, 4 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNDX’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 2 bullish TA indicator(s).

  • SNDX’s TA Score: 4 bullish, 6 bearish.
  • SRRK’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than SRRK.

Price Growth

SNDX (@Biotechnology) experienced а +20.78% price change this week, while SRRK (@Biotechnology) price change was -1.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was +3.12%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

SNDX is expected to report earnings on Aug 11, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($2.89B) has a higher market cap than SNDX($930M). SNDX YTD gains are higher at: -18.230 vs. SRRK (-29.523). SRRK has higher annual earnings (EBITDA): -250.12M vs. SNDX (-313.82M). SNDX has more cash in the bank: 583M vs. SRRK (437M). SRRK has less debt than SNDX: SRRK (65.1M) vs SNDX (346M). SNDX has higher revenues than SRRK: SNDX (23.7M) vs SRRK (0).
SNDXSRRKSNDX / SRRK
Capitalization930M2.89B32%
EBITDA-313.82M-250.12M125%
Gain YTD-18.230-29.52362%
P/E RatioN/AN/A-
Revenue23.7M0-
Total Cash583M437M133%
Total Debt346M65.1M531%
FUNDAMENTALS RATINGS
SNDX vs SRRK: Fundamental Ratings
SNDX
SRRK
OUTLOOK RATING
1..100
861
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
8942
P/E GROWTH RATING
1..100
3100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRRK's Valuation (64) in the Biotechnology industry is in the same range as SNDX (84). This means that SRRK’s stock grew similarly to SNDX’s over the last 12 months.

SRRK's Profit vs Risk Rating (79) in the Biotechnology industry is in the same range as SNDX (100). This means that SRRK’s stock grew similarly to SNDX’s over the last 12 months.

SRRK's SMR Rating (98) in the Biotechnology industry is in the same range as SNDX (98). This means that SRRK’s stock grew similarly to SNDX’s over the last 12 months.

SRRK's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for SNDX (89). This means that SRRK’s stock grew somewhat faster than SNDX’s over the last 12 months.

SNDX's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for SRRK (100). This means that SNDX’s stock grew significantly faster than SRRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNDXSRRK
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
77%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME30.862.81
+10.02%
GameStop Corp
TSLA341.046.42
+1.92%
Tesla
BTC.X111673.2800001995.203100
+1.82%
Bitcoin cryptocurrency
SPY583.090.23
+0.04%
SPDR® S&P 500® ETF
AAPL201.36-0.73
-0.36%
Apple

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+1.50%
IDYA - SNDX
52%
Loosely correlated
N/A
ETNB - SNDX
51%
Loosely correlated
N/A
KRYS - SNDX
51%
Loosely correlated
-1.10%
CGON - SNDX
50%
Loosely correlated
-1.75%
KYMR - SNDX
50%
Loosely correlated
+0.13%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ONCY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ONCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-0.85%
ONCY - SRRK
41%
Loosely correlated
-4.54%
PLRX - SRRK
40%
Loosely correlated
N/A
SNDX - SRRK
39%
Loosely correlated
+1.50%
VTGN - SRRK
39%
Loosely correlated
N/A
ALT - SRRK
37%
Loosely correlated
+3.22%
More